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1. Introduction 
The neuropeptide oxytocin (OT) is synthesized in magnocellular neurons of the 
paraventricular and supraoptic nuclei of the hypothalamus and released from axon 
terminals in the neurohypophysis into the general circulation. However, OT is also released 
from somata and dendrites of magnocellular neurons into the brain [1]. OT release from 
axon terminals, somata and dendrites is regulated by not only activity-dependent Ca2+ 
influx, but also by mobilization of Ca2+ from intracellular Ca2+ stores [2, 3]. CD38, a 
transmembrane glycoprotein with ADP-ribosyl cyclase activity, plays a critical role in 
mobilization of intracellular Ca2+, and therefore CD38 gene knockout (CD38-/-) mice show 
low plasma OT concentrations [2]. On the other hand, CD38 is not responsible for the 
secretion of arginine vasopressin, which is another neurohypophyseal hormone [2]. 
Perioherally, OT promotes milk ejection in females and penile erection in males [4]. In 
addition, studies using OT gene knockout (OT-/-), OT receptor gene knockout (OTR-/-), or 
CD38-/- mice, in which OT signaling would be disrupted, were performed to investigate the 
roles of OT in the central nervous system [5, 6]. 
While OT+/+ male mice showed a decline in the time investigating a female mouse during 
repeated pairings with full recovery following the introduction of a new female, OT-/- male 
mice show no such decline [7]. The results suggested that OT-/- male mice fail to develop 
social memory. Moreover, in a different experimental paradigm, OT-/- mice showed the same 
sociability, which was reflected as more time spent with a novel mouse as compared to time 
spent with a novel object, and preference for social novelty, which is reflected as more time 
spent with a second novel mouse as compared to time spent with a non-stranger mouse, as 
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OT+/+ mice [8]. This experimental paradigm contains no memory component. Taken 
together, OT-/- mice exhibit impairments specific to social memory rather than deficits in 
general sociability. In addition, OT-/- infant mice show fewer call rates in ultrasonic 
vocalizations in response to maternal separation compared to OT+/+ infant mice [9], so OT-/- 
mice may be less emotional in the mother-infant relationship. 
When OTR-/- dams retrieve their infant mice scattered in the home gage, they take a longer 
time and spend less time crouching over infant mice than OTR+/+ dams. OTR-/- infant mice 
show decreased ultrasonic vocalizations as seen in OT-/- infant mice [10]. While OTR+/+ mice 
spend a longer time exploring a cage occupied by an unfamiliar mouse than an empty cage, 
OTR-/- mice spend the same time in exploring both cages [11]. Interestingly, forebrain-
restricted OTR-/- male mice show a decline in the investigation time with the same female 
mice during repeated pairings and show full recovery following the introduction of a new 
female as with OTR+/+ male mice [12].  
CD38-/- male mice also show no decline in the investigation time with the same female 
mouse during repeated pairings unlike CD38+/+ male mice [2]. CD38-/- infant mice show 
fewer call rates in ultrasonic vocalizations in response to maternal separation compared 
with CD38+/+ infant mice [13]. 
OT-/-, OTR-/-, and CD38-/- mice show similar impairments in social memory and emotional 
relationship to the dam on isolation. Thus, investigations performed in OT-related knockout 
mice suggested the possible roles of OT as a sociability hormone. OT signaling in the brain 
was expected to play an important role in sociality in humans and to contribute to the 
etiologies of psychiatric disorders with social deficits, such as autism, which has been 
suggested to involve low plasma concentrations of OT [14]. 
Autism spectrum disorder (ASD) is a diagnostic continuum, which encompasses autistic 
disorder (autism), childhood disintegrative disorder, Asperger’s disorder, and pervasive 
developmental disorder not otherwise specified in the Diagnostic and Statistical Manual of 
Mental Disorders (DSM) [15] and is intended to be designated so in a new version (DSM-5). 
Qualitative impairments of social interaction (social impairments) would be regarded as the 
major core symptom of ASD with repetitive and restrictive behaviors as another core 
symptom. However, social impairments imply wide-ranging symptoms from lack of 
declarative pointing, immediate echolalia, and failure to develop reciprocal peer 
relationships to very slight deficits identified only by detailed examinations combined with 
diagnostic tools, such as an advanced task for theory of mind [16]. Individuals with ASD, 
therefore, may not be diagnosed until adulthood [17]. 
While symptoms designated and conceptualized as impairments of social interaction are 
indispensable to the diagnosis of ASD and are easily identified in mentally retarded 
subjects with typical ASD, such as autism, weaker phenotypes of social impairments 
would involve a complicated subject of considering the symptomatology of ASD. 
Behavioral signs of social impairments in ASD have been suggested to emerge as a decline 
in social engagement, such as gazing on faces and social smiles, between 6 and 12 months 
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of age [18]. These results imply that ASD is a nearly innate rather than acquired disease, 
although it could not be excluded that exogenous factors may exert adverse effects on 
newborns within the 6 months after birth. However, the clear boundary between the 
conditions with and without ASD could not be defined in research or from a clinical 
perspective. Autistic traits in the general population are common and show a continuous 
distribution [19]. Moreover, the symptom of social impairment has a different meaning in 
nature compared to all other medical symptoms. A fasting blood sugar level of 150 mg/dL 
in an individual with diabetes mellitus is an objective and independent measurement. 
Social impairments in an individual with ASD are by no means objective and 
independent, especially in the boundary region between the conditions with and without 
ASD. The term “social” has relevance to human “society.” Human society is the whole 
that has been shaped by innumerably iterated social interactions among humans from 
time immemorial, and cannot be defined from an external standpoint. While behaviors 
exhibited by individuals with ASD may look more or less deviant from the viewpoint of 
human society, they adapt themselves to human society unremarkably in some cases and 
deviate from it directly in other cases. Social impairments in ASD subjects cannot be 
anchored exactly in the context of real-life environments. Therefore, it is very difficult to 
determine how symptoms of social impairment should be evaluated in treatment of 
patients with ASD. 
In this article, we first discuss the influence of intranasally administered OT on sociality in 
human adults. We further examine the results obtained from four studies in which the 
effectiveness of intranasally or intravenously administered OT was investigated in ASD 
subjects. Moreover, we discuss long-term clinical trials in progress, for which we searched 
the public databases, of intranasally administered OT in subjects with ASD in randomized, 
double-blind, placebo-controlled designs. Finally, we consider the improvements in social 
impairments in the treatment of patients with ASD. 
2. Effectiveness of intranasally administered OT on social cognition and 
prosocial behaviors in healthy adults 
We consider that reciprocal interaction with others would go through the processes of self-
consciousness as a construct deeply embedded in human society, social cognition, and 
prosocial behavior. Self-consciousness (i.e., self-representation or self-reference) may be a 
key concept in considering the psychopathology of ASD [20]. Can individuals with 
attenuated self-consciousness distinguish self from others in a social context? Children and 
adolescents with ASD made fewer statements classified as the social not but physical, active 
and psychological category compared to non-ASD subjects [21]. Typical interaction with 
others may be realized only under the conditions of typical self-consciousness. While 
biological investigations of self-consciousness have been performed using functional 
magnetic resonance imaging in ASD and healthy individuals [22, 23], the effects of OT on 
self-consciousness in humans remain unclear. 
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Social cognition implies important factors underlying not just face-to-face exchanges with 
others but also even circumstances alone in a crowd. People may wonder “Who is he?” 
“What has my daughter been thinking?” or “That person is watching me”. All of this 
corresponds to social cognition. Prosocial behavior implies the favorable or unfavorable 
impressions that a person has toward others, and the following actions based on these 
impressions. People are impressed by others’ behaviors and may bring these impressions 
into actions: “He looks trustworthy. I will consult with him about which course to take after 
graduation,” “I hate people who discriminate against the weak. So, I will not talk to him.” 
These are prosocial behaviors. 
There have been many studies regarding the effects of OT on social cognition and prosocial 
behavior in healthy adults since the pioneering study by Kosfeld et al. [24] Interest in OT has 
increased due to the positive results obtained: e.g., strengthening of memory for faces [25] 
and increased emotional empathy [26] in social cognition, increased generosity [27] and 
trust [28] in prosociality. However, the results are inconsistent on closer inspection (for 
details, see [29]). For example, 259 healthy students participated in a study regarding the 
effects of OT on cooperative behavior in a randomized, double-blind, placebo-controlled 
design [30]. Participants played two economic games, which were a Coordination Game 
with strong incentives to cooperate and a Prisoner’s Dilemma game with weak cooperative 
incentives, after one-half of them talked together and the other half spoke to no-one. The 
former group receiving OT showed more cooperation only in the Coordination Game than 
participants receiving placebo. However, the latter group receiving OT showed less 
cooperation only in the Cooperation Game than participants receiving placebo. Prosocial 
behaviors on receiving OT proceeded in the opposite directions according to whether social 
information was presented previously.  
Based on the review of Bartz et al. [29], of 14 studies investigating social cognition, nine 
(69.2%) showed that OT exerted a significant main effect on the outcome compared to 
placebo (Table 1). Eight of these nine studies suggested that the effect of OT was 
significantly modulated by situational differences or individual factors. However, there was 
a marginal trend between the distributions of two categorical variables of OT effect and 
modulated OT effect (Fisher’s exact test, P = 0.095). 
   Modulated oxytocin effect Fisher’s exact test 
   Yes No  
Social 
cognition 
Oxytocin effect 
Significant 8 1 
P = 0.095 
Null 2 3 
Prosociality Oxytocin effect 
Significant 5 12 
P = 0.006 
Null 12 3 
Table 1. Relationship between oxytocin effect and modulated oxytocin effect (designed according  
to [25]) 
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Of 32 studies investigating prosocial behavior, 17 (53.1%) showed that OT exerted a 
significant main effect on the outcome compared to placebo. Five of these 17 studies 
suggested that the effect of OT was significantly modulated by situational differences or 
individual factors. On the other hand, 12 of 15 studies without a significant main effect of 
OT were significantly modulated by situational differences or individual factors. The 
distribution of two categorical variables was significantly different (P = 0.006). The more 
these factors affect study participants, the less the effects of OT emerge in them. That is, the 
effects of OT on sociality, especially prosocial behavior, may be affected by external factors 
in addition to the function of OT itself and, moreover, external factors may show 
paradoxical effects. For example, 66 healthy adults participated in a money game, in which 
they rated their emotions (envy and gloating) toward their opponents when they gained 
more or less money, in double-blind, placebo-controlled, with-in subject design [31]. 
Interestingly, OT increased the envy ratings when the participant gained less money and the 
gloating ratings when they gained more money compared to placebo. 
While early research that suggested effectiveness of OT in psychiatric diseases such as social 
anxiety disorder and ASD generated considerable enthusiasm, the reasons for the 
inconsistent and paradoxical results of OT on sociality in healthy humans remain 
unresolved. However, the pathophysiology of ASD has not yet been elucidated and no 
effective treatments for social impairments in ASD exist. It would be useful to investigate 
whether OT can improve the core symptoms of ASD. 
3. Effectiveness of intranasally or intravenously administered OT in ASD 
subjects 
Four randomized, double-blind, placebo-controlled trials of short-term OT administration in 
subjects with high-functioning ASD have been published since 2003 (Table 2) [32－35]. 
Reference 
number 
n Male 
gender
Age 
(years)
Intelligence 
quotient 
Medication 
method 
Oxytocin 
dose 
Outcomes 
32 15 14 19－56 74－110 Intravenously 10U Repetitive behavior 
scale 
33 15 14 19－56 74－110 Intravenously 10U Comprehension of 
affective speech 
34 13 11 17－39 unknown Intranasally 24 IU Social ball tossing 
game 
35 16 16 12－19 unknown Intranasally 18 or 24 
IU 
Reading the Mind 
in the Eyes-Revised 
Table 2. Randomized, double-blind, placebo-controlled trials of short-term oxytocin administration in 
subjects with high-functioning autism spectrum disorder  
The designs were naturally different between these studies in terms of age and gender of 
participants, medication methods, doses of OT and outcomes, so no conclusions could be 
drawn regarding the treatment of ASD patients based on a single-dose design. However, OT 
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may play a role in alleviating repetitive symptoms [32] and modifying social impairments 
[33－35]. 
With regard to social impairments, Hollander et al. investigated the effectiveness of 
intravenously administered OT on comprehension of affective speech in 15 subjects with ASD 
in a randomized, double-blind, placebo-controlled, cross-over design [33]. The task was fairly 
easy for the participants resulting in the same improvements of scores of those who were 
administered placebo in the first condition as those who were administered OT in the first 
condition. However, after an interval between the first and second conditions (days: mean = 
16.07; SD = 14.26), the scores at baseline in the second condition were retained in the participants 
administered OT and dropped in those administered placebo. These results suggested that OT 
may play a role in social memory acquisition in social cognition in ASD subjects. 
Andari et al. investigated the effectiveness of intranasally administered OT on trust and 
preference toward opponent players using a social ball tossing game in 13 subjects with ASD 
by randomized, double-blind, placebo-controlled, within-subject design [34] (No results of face 
perception tasks shown in the study are noted here). ASD subjects administered OT trusted 
more and showed stronger preference for good than bad opponent players regardless of the 
perception of monetary rewards. No significant differences were found under placebo 
conditions. These results suggest that OT may play a role in prosocial behavior in subjects with 
ASD. Moreover, it was noted that plasma OT concentration at 10 min after nasal 
administration of OT show a significant increase compared to baseline concentration. 
Guastella et al. investigated the effectiveness of intranasally administered OT on emotion 
recognition using the Reading the Mind in the Eyes Test-Revised [36] in 16 subjects with 
ASD by randomized, double-blind, placebo-controlled, cross-over design [35]. The 
improved performance by OT compared to placebo was restricted to the younger 
participants aged 12 to 15 and easy items in the test. These results suggest that OT may play 
a role in emotion recognition in social cognition for ASD subjects, although age and task 
difficulty may act as modulators. 
Taken together, short-term (continuous intravenous infusion over 4 h or nasal spray of 
certain doses at a time) administration of OT may show effectiveness on social cognition and 
prosocial behavior in ASD subjects with situational differences or individual factors as 
confounders taken into account. The next step should be to investigate whether long-term 
administration of OT modulates social impairments in ASD.  
4. Long-term randomized, double-blind, placebo-controlled trials of OT 
in subjects with ASD registered in the public databases 
We searched the public databases, i.e., Clinicaltrials.gov (http://clinicaltrials.gov), UMIN 
Clinical Trials Registry (http://www.umin.ac.jp/ctr/index-j.htm), and Australian New Zealand 
Clinical Trials Registry (http://www.anzctr.org.au/), for long-term clinical trials of OT in ASD. 
In other databases of EU Clinical Trials Register (https://www.clinicaltrialsregister.eu/) and 
ISRCTN Register (http://www.isrctn.org/), we could not obtain the detailed information 
about long-term clinical trials of OT in ASD. 
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Nine pioneering clinical trials are in progress (Table 3). Although there is considerable 
diversity in age and gender of participants, oxytocin doses and trial duration, primary and 
secondary outcome measures would be the most noticeable items and are discussed here. 
Registered identifier Registered
date
Estimated 
enrollment 
Age
(years)
Gender Intellectual 
disability 
NCT01417026 11 August 2011 68 12－17 Male Profound mental retardation 
excluded 
NCT01337687 10 December 2010 34 18－55 Both Excluded 
NCT01256060 22 November 2010 84 12－18 Both Excluded 
UMIN000003812 7 January 2010 20 10－14 Male Not excluded 
UMIN000005211 8 March 2011 60 >15 Both Excluded 
UMIN000007122 1 February 2012 20 18－54 Male Excluded 
UMIN000007250 9 February 2012 30 15－44 Male Restricted to subjects with 
intellectual disability 
ACTRN12611000061932 17 January 2011 40 3－8 Both Not excluded 
ACTRN12609000513213 29 June 2009 40 12－18 Male Excluded 
Registered number Oxytocin 
doses per 
day
Oxytocin
duration
Primary and secondary outcome measures 
NCT01417026 24 IU 5 days Part/Whole Identity Test, Reading the Mind in the Eyes 
Test,social attention, reward/motivation, perception, and 
cognition tasks
NCT01337687 48 IU 8 weeks Clinical Global Impressions Scale- Severity and 
Improvement. Yale Brown Obsessive Compulsive Scale, 
Repetitive Behavior Scale－Revised, Diagnostic Analysis 
of Nonverbal Accuracy－2
NCT01256060 0.8 IU / 
kg 
12 weeks Diagnostic Analysis of Nonverbal Accuracy, Social 
Responsiveness Scale, Clinical Global Impressions Scale－
Improvement, Repetitive Behavior Scale－Revised, Child 
Yale-Brown Obsessive-Compulsive Scale 
UMIN000003812 Maximum
24 IU
12 
months
Child Behavior Checklist, Autism Diagnostic Observation 
Schedule, Childhood Autism Rating Scale 
UMIN000005211 Unknown Unknown Aberrant Behavior Checklist, Childhood Autism Rating 
Scale, Zung Self-Rating Depression Scale, State-Trait 
Anxiety Inventory
UMIN000007122 48 IU 6 weeks Autism Diagnostic Observation Schedule, Childhood 
Autism Rating Scale 2, Psychological paradigms to test 
social cognition and behavior 
UMIN000007250 16 IU 8 weeks Childhood Autism Rating Scale, Clinical Global Impressions, 
Aberrant Behavior Checklist, Global Assessment of 
Functioning, Interaction Rating Scale Advanced 
ACTRN12611000061932 Maximum
12 IU 
5 weeks Positive social interaction, Severity of repetitive behavior, 
Clinical Global Impressions, Preferential attention to social 
stimuli, Developmental Behavior Checklist, Social 
behavior scale
ACTRN12609000513213 12－18 
IU
8 weeks Social Responsiveness Scale, Reading the Mind in the Eyes 
Test, Repetitive Behavior Scale, Clinician Global Assessment 
Table 3. Randomized, double-blind, placebo-controlled trials of intranasally short-term oxytocin 
administration in subjects with high-functioning autism spectrum disorder based on the public databases 
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The Social Responsiveness Scale provides quantitative measurements of social impairments 
in ASD by assessing domain of sociality such as social awareness and social information 
processing [37], and has been used as an outcome measure for interventions [38, 39]. The 
Reading the Mind in the Eyes Test [36] measures an aspect of social cognition by having the 
subjects assess emotion through the look of an actor’s eye in photographs and has been 
adopted in many experimental trials [35, 40]. The Diagnostic Analysis of Nonverbal 
Accuracy Scale measures receptive and expressive abilities for receiving and sending 
emotions in faces, gestures, postures, and prosody [41], and has been used in the researches 
of not only ASD [42] but also of other mental disorders [43]. The Childhood Autism Rating 
Scale helps to identify subjects with ASD and determine symptom severity and has been 
commonly used in research and clinical settings. The scale assesses various domains of 
symptoms in ASD, including social impairments. The Autism Diagnostic Observation 
Schedule is a tool for assessment of symptoms of ASD through structured and semi-
structured activities with subjects and provides scores in communication, social, and 
restricted and repetitive domains [44]. This tool has been regarded as the gold standard for 
assessing and diagnosing ASD. The Interaction Rating Scale Advanced assesses a practical 
index of social skills using five-minute video recorded interaction session [45]. It is 
interesting to note that this new tool may provide a validated measure of social impairments 
of ASD. The evaluations mentioned above provide quantitative values of social impairments 
of ASD based on caregivers’ self-reports or behavioral observations. 
At present, there is no commonly used assessment of symptoms in ASD, especially social 
and communication domains, for any interventions in contrast to the Positive and Negative 
Symptom Scale in schizophrenia and Hamilton Rating Scale for Depression in major 
depressive disorder, which are widely used as almost definitive measures. In the well-
known research in which risperidone, a second-generation antipsychotic, was shown to be 
effective for reduction of irritability in subjects with ASD, the authors stated that they were 
unable to identify a validated measure for the core symptoms of ASD, i.e., social 
impairments [46].  
A key question is whether these outcome measures could be used to sensitively assess 
improvements in sociality, which may only be subtle changes. This question remains 
unanswered before publication of the results of these trials. 
5. What are the improvements of social impairments in the treatments of 
patients with ASD? 
Social impairments in ASD have fundamentally different meanings from personality 
characteristics, such as introversion, interpersonal tension, or aloofness. Infants or 
preschool children with ASD may indicate very unique and impressive behaviors in the 
social context, which substantially reflect the disparity between typically developing 
children and children with ASD in social interaction. Here, we will describe pointing 
behaviors as an illustration. 
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When one points at something, others are invariably around. When one points at something, 
one invariably attempts to convey any information to others around. A toddler pulls his/her 
mother’s sleeve, points to a miniature car on a shelf, and then looks at his/her mother’s face 
(requesting pointing). When a preschool child sees a rainbow in the sky after rain, he/she runs 
up to his/her mother, takes her to the garden, and points to the rainbow while looking at her 
(declarative pointing). Liszkowski et al. found that twelve-month-old infants show different 
attitudes according to experimenter’s reactions when infants point declaratively [47]. When 
experimenters responded to infants’ declarative pointing but attended an incorrect referent 
with positive attitude, infants repeated pointing to redirect the experimenters’ attention. When 
experimenters identified the correct referent with negative attitude, infants did not repeat 
pointing. When experimenters identified the correct referent and shared interest in it, infants 
appeared satisfied. Pointing is a prototypical behavior of interpersonal exchange, i.e., sociality. 
Toddlers with ASD display a reduced incidence of declarative pointing compared to 
typically developing toddlers [48]. Declarative pointing constitutes a significantly diagnostic 
sign as well as social interest and joint attention for early detection of ASD [49]. Individuals 
with ASD have an innate disability in the social domain. 
We consider that it would be essential to refer to one’s own self and others if social 
impairments in ASD are discussed, because our own selves are embedded in a society full of 
others [20]. Individuals with ASD may be unable to mentalize the inner states of typically 
developing individuals, and this raises the question of whether typically developing 
individuals can mentalize the inner states of individuals with ASD. “Theory of mind” tasks 
would be regarded as tasks in ASD with “altered” self-consciousness proposed by 
individuals with “intact” self-consciousness.  
According to the standpoint of traditional German psychopathology, self-consciousness 
(Ichbesstsein in German) is formally comprised of four prototypical representations. First, 
one’s own self is identical at all times. Second, one’s own self is always consistent. Third, all 
of one’s own acts belong to one’s own self. Finally, one’s own self differs from others’ own 
self. These representations deeply embedded in social interactions are intrinsically self-
evident and underlie interpersonal exchange of sociality. While one exists almost without 
reflection on these representations in daily life, severe disruption of self-consciousness 
would have fairly serious consequences, such as dissociative identity crisis, doppelganger, 
xenopathic experiences and delusions of possession. Interestingly, children with ASD 
performed significantly less well on the self-test question than the other-person test question 
using tasks in which participants have to reflect an awareness of one’s own prior belief [50]. 
These results suggest that individuals with ASD represent altered self-consciousness as 
mentioned above: “all of one’s own acts belong to one’s own self.” 
Although self-consciousness have been investigated using functional magnetic resonance 
imaging in ASD and healthy individuals [22, 23], the effects of OT on self-consciousness in 
humans have not been examined. 
It is essential but difficult to answer questions regarding improvements of social 
impairments associated with treatment of patients with ASD. However, it may be useful to 
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assess self-consciousness, although there is as yet no suitable test to examine representations 
of self-consciousness available in ASD research. 
6. Conclusion 
We hypothesized that OT signaling in the central nervous system may play a significant role 
in the pathophysiology of ASD based on studies using OT-related knockout mice, 
effectiveness in social context of OT to healthy subjects, and the results of short-term 
administration of OT on social impairments in ASD subjects. Long-term clinical trials of OT 
in ASD subjects are currently in progress. It is difficult to determine how symptoms of social 
impairment should be assessed in interventions in patients with ASD, although 
investigation of self-consciousness may provide important insights regarding this issue. 
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